WuXi PharmaTech Healthcare Fund I L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Adagene Inc. Ordinary shares, par value US$0.0001 per share (ADAG)

Filing Manager: WuXi PharmaTech Healthcare Fund I L.P.
Reporting Manager: WuXi PharmaTech Healthcare Fund I L.P.
Security: Adagene Inc. Ordinary shares, par value US$0.0001 per share
Symbol: ADAG
Shares outstanding: 58.9M shares
Disclosed Ownership: 4.12M shares
Ownership: 7%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 05:42 PM
Date of event: Sep 30, 2025
Previous filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
WuXi PharmaTech Healthcare Fund I L.P.	7%	4.12M	0	4.12M	/s/ Ming Shi	Ming Shi, Director
WuXi AppTec Co., Ltd.	7%	4.12M	0	4.12M	/s/ Ming Shi	Ming Shi, Director